The Swiss fintech landscape has encountered significant hurdles in recent years, particularly in 2025, as venture capital (VC) funding dwindled in favor of biotech and information and communication technology (ICT). This shift in investment priorities reveals a broader trend that could reshape the financial technology ecosystem in Switzerland.
Declining Fintech Funding
In 2025, Swiss fintech companies amassed a mere CHF 236.4 million from 30 funding transactions. This figure comprises only about 8% of the total VC funding, positioning fintech fifth in terms of funding volume and sixth in deal count. This decline starkly contrasts with the vibrant years of 2021 and 2022 when fintech commanded the top ranks in both funding amounts and deal frequency.
To put this in perspective, fintech companies in Switzerland raised CHF 857 million in 2021, which represented an astonishing 28% of the CHF 3 billion invested in Swiss startups that year. The drop in funding signals a shift in investor confidence and interest, and the implications for the sector are profound.
The Size of Fintech Deals
The modest performance of fintech funding is particularly evident in the size of the transactions. In 2025, only two fintech deals made it to the top 20 financing rounds, both of which were under CHF 100 million. Wefox, an insurance broker, secured CHF 70.88 million, while Sygnum Bank raised CHF 52.93 million to bolster its market presence in the EU and Hong Kong.
These figures indicate a stark contrast to the explosive growth within other sectors, emphasizing the challenges that fintech startups must navigate in a competitive environment.
Biotech and ICT Surge Ahead
While fintech struggled, the ICT sector demonstrated remarkable resilience and growth. Funding for ICT companies surged from CHF 315.9 million in 2024 to CHF 773.6 million in 2025, reflecting a 150% year-over-year increase. This growth allowed ICT to capture 26.24% of all VC funding, marking a return to levels seen in 2019.
Biotech also emerged as a significant player, posting an impressive CHF 946.4 million in funding—25% higher than its previous peak in 2020. This growth secured biotech a 32.1% share of the total VC funding, underscoring its position among the top three sectors for the third consecutive year.
Renewed Interest in Early-Stage Investments
A notable trend in 2025 was the resurgence of early-stage investments. Overall VC funding activity in Switzerland grew by 23.9% year-over-year, reaching CHF 2.948 billion. This growth signifies a recovery from the financing challenges of previous years, driven by a renewed appetite for risk.
Early-stage financing saw a remarkable 73% increase, with CHF 1.116 billion invested. Seed rounds also experienced a boost, with CHF 298 million allocated—indicating a significant recovery in investor confidence.
Optimism Among Investors
A survey conducted at the end of 2025 revealed a sense of renewed optimism among domestic investors. Approximately 55% of respondents had made up to five new investments, while around 20% reported making up to ten. Looking ahead, a quarter of investors plan to commit CHF 51 million to CHF 120 million over the next three years—more than double the number of investors willing to make similar commitments the previous year.
This optimism suggests a potential turning point for the Swiss investment landscape, particularly as more funds are anticipated to enter the market.
Contrast with Global Trends
In stark contrast to the challenges faced by Swiss fintech, global fintech funding exhibited a robust recovery in 2025. Worldwide, fintech companies secured US$52.7 billion, accounting for 11% of the total global venture funding. This increase of 35.5% year-over-year indicates a strong global appetite for fintech investments, with the sector positioned as the second largest startup vertical behind artificial intelligence (AI).
The payments sector dominated the global fintech landscape, capturing 23.33% of all fintech funding in 2025, followed by digital lending and banking.
Future of Swiss Fintech
The current landscape presents both challenges and opportunities for the Swiss fintech sector. As venture capital continues to flow into biotech and ICT, fintech must innovate and adapt to regain investor interest. The shift in funding priorities could serve as a catalyst for fintech startups to rethink their strategies and explore new avenues for growth.
The potential for collaboration between fintech, biotech, and ICT may also provide a pathway for revitalization. By leveraging synergies across these sectors, fintech companies can harness emerging technologies and trends to enhance their offerings and attract investment.
Key Takeaways
- Swiss fintech funding dropped to CHF 236.4 million in 2025, reflecting a significant decline in investor interest.
-
Biotech and ICT emerged as the top sectors for VC funding, with biotech securing CHF 946.4 million and ICT reaching CHF 773.6 million.
-
Early-stage investments surged, indicating a renewed appetite for risk among investors.
-
Global fintech funding rebounded to US$52.7 billion, highlighting a stark contrast to the struggles faced by the Swiss sector.
-
Optimism among domestic investors is growing, with plans for increased investments in the coming years.
In conclusion, the Swiss fintech sector is at a crossroads. While it grapples with declining funding, the burgeoning interest in biotech and ICT presents an opportunity for strategic pivots and collaborations. Adaptation and innovation will be key for fintech to regain its footing and thrive in an evolving investment landscape.
Read more → fintechnews.ch